Cardiovascular disease in cancer survivors
Abstract
Certain cancer therapies, including radiation therapy and some types of chemotherapies, are associated with increased risk of cardiovascular disease (CVD) and events. Some of these effects such as those presented by anthracyclines, radiation therapy, cisplatin, as well as those presented by hormone therapy for breast cancer—usually taken for many years for some breast and prostate cancers—are long-lasting and associated with cardiovascular events risk more than 20 years after cancer treatment. Cardiovascular testing, diagnostic assessment of suspected cardiovascular symptomatology, as well as laboratory tests for CVD risk factors are imperative. The early recognition and treatment of CVD processes that arise in survivorship years is pivotal, with specific attention to some CVD processes with specific suggested treatment modalities. Preventive measures include adequate screening, the use of medications such as ACE inhibitors/angiotensin receptor blockers and/or beta blockers, statin therapy and aspirin in persons who warrant these medications, as well as therapeutic lifestyle modifications such as exercise/physical activity, weight loss and appropriate diet for a healthy lifestyle. Periodic follow-up with a good primary care physician who understands the risks associated with cancer therapy is important, and referral to onco-cardiology for further management of cardiovascular risk in these survivors is based on a patient’s cardiovascular risk level and the type, amount and duration of cancer therapies received during the patient’s lifetime.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S. M., Négrier, S., Szczylik, C. A., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,752 · see citing works
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974 · see citing works
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T. I., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N. M., Hobbie, W. L., Kadan‐Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597 · see citing works
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G. A., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,646 · see citing works
Congestive heart failure in patients treated with doxorubicin
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,315 · see citing works
Wilke, H., Muro, K., Cutsem, E. V., Oh, S., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,200 · see citing works
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer‐Crosbie, M., Gáname, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,802 · see citing works
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D. M., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,741 · see citing works
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
The Breast International Group (BIG) 1-98 Collaborative Group (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,581 · see citing works
Wells, S. A., Robinson, B. G., Gagel, R. F., Dralle, H., Fagin, J. A., Santoro, M., Baudin, É., Elisei, R., Jarząb, B., Vasselli, J. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5040 · Cited by 1,556 · see citing works
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Pérez‐Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,397 · see citing works
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M., Marcom, P. K., Fehrenbacher, L., Dickler, M. N., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,303 · see citing works
Anthracycline-Induced Cardiomyopathy
Cardinale, D. M., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., Giacomi, G. D., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,110 · see citing works
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkelä, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L. L. H., Woulfe, K. C., Pravda, E. A., Cassiola, F. M., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,081 · see citing works
Darby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049 · see citing works
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030 · see citing works
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA · doi:10.1001/jama.1991.03470120074036 · Cited by 967 · see citing works
Overview of the main outcomes in breast-cancer prevention trials
Cuzick, J. M., Powles, T. J., Veronesi, U., Forbes, J., Edwards, R. P., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 963 · see citing works
Tabernero, J., Yoshino, T., Cohn, A. L., Obermannova, R., Bodoky, G., Garcia-Carbonero, R., Ciuleanu, T.-E., Portnoy, D. C., Van Cutsem, E., Grothey, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70127-0 · Cited by 952 · see citing works
Patnaik, J. L., Byers, T., DiGuiseppi, C. G., Dabelea, D., & Denberg, T. D. (2011) · Breast Cancer Research · doi:10.1186/bcr2901 · Cited by 874 · see citing works
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., Durand, J., Gibbs, H. H., Zafarmand, A. A., & Ewer, M. S. (2004) · Circulation · doi:10.1161/01.cir.0000133187.74800.b9 · Cited by 842 · see citing works
Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., Cohen, V., Banchs, J. A., Carver, J. R., Wiegers, S. E., et al. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.973321 · Cited by 813 · see citing works
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Dowsett, M., Cuzick, J. M., Ingle, J. N., Coates, A. S., Forbes, J., Bliss, J. M., Buyse, M. E., Baum, M., Buzdar, A. U., Colleoni, M. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1274 · Cited by 809 · see citing works
Armstrong, G. T., Liu, Q., Yasui, Y., Neglia, J. P., Leisenring, W., Robison, L. L., & Mertens, A. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1425 · Cited by 776 · see citing works
Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin's Disease
Hancock, S. L. (1993) · JAMA · doi:10.1001/jama.1993.03510160067031 · Cited by 747 · see citing works
Mertens, A. C., Liu, Q., Neglia, J. P., Wasilewski, K., Leisenring, W. M., Armstrong, G. T., Robison, L. L., & Yasui, Y. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn310 · Cited by 730 · see citing works
Statin Use and Reduced Cancer-Related Mortality
Klop, C., Driessen, J. H. M., & de Vries, F. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1214827 · Cited by 722 · see citing works
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Özkök, A., & Edelstein, C. L. (2014) · BioMed Research International · doi:10.1155/2014/967826 · Cited by 707 · see citing works
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity
Ewer, M. S., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.827 · Cited by 646 · see citing works
Bosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales‐Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632 · see citing works
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Schmidinger, M., Zielinski, C. C., Vogl, U. M., Bojic, A., Bojić, M., Schukro, C., Ruhsam, M., Hejna, M., & Schmidinger, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6331 · Cited by 611 · see citing works
Rini, B. I., Cohen, D. P., Lu, D. R., Chen, I., Hariharan, S., Gore, M. E., Figlin, R. A., Baum, M. S., & Motzer, R. J. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr128 · Cited by 580 · see citing works
Bowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A. B., Davis, R. L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs317 · Cited by 566 · see citing works
Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
Meinardi, M. T., Gietema, J. A., Graaf, W. T. A. V. D., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., de Vries, E. G. E., Willemse, P. H. B., Mulder, N. H., van den Berg, M. P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1725 · Cited by 488 · see citing works
Lancellotti, P., Nkomo, V. T., Badano, L. P., Bergler-Klein, J. K., Bogaert, J. G., Davin, L., Cosyns, B., Coucke, P. A., Dulgheru, R., Edvardsen, T., et al. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.07.005 · Cited by 485 · see citing works
Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
Reulen, R. C. (2010) · JAMA · doi:10.1001/jama.2010.923 · Cited by 447 · see citing works
Daunomycin-induced cardiotoxicity in children and adults
Hoff, D. D. V., Rozencweig, M., Layard, M. W., et al. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90315-1 · Cited by 437 · see citing works
Haugnes, H. S., Wethal, T., Aass, N., Dahl, O., Klepp, O., Langberg, C. W., Wilsgaard, T., Bremnes, R. M., & Fosså, S. D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9362 · Cited by 407 · see citing works
Cardiac Complications of Thoracic Irradiation
Jaworski, C., Mariani, J. A., Wheeler, G., & Kaye, D. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.090 · Cited by 395 · see citing works
Asymptomatic cardiac disease following mediastinal irradiation
Heidenreich, P. A., Hancock, S., Lee, B. K., Mariscal, C. S., & Schnittger, I. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00759-9 · Cited by 392 · see citing works
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
van de Velde, C. J., Rea, D., Seynaeve, C., Putter, H., Hasenburg, A., Vannetzel, J.-M., Paridaens, R., Markopoulos, C., Hozumi, Y., Hille, E. T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62312-4 · Cited by 372 · see citing works
Seicean, S., Seicean, A., Plana, J. C., Budd, G. T., & Marwick, T. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.067 · Cited by 325 · see citing works
Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
Choueiri, T. K., Mayer, E. L., Je, Y., Rosenberg, J. E., Nguyen, P. L., Azzi, G., Joaquim Bellmunt, B., Burstein, H. J., & Schutz, F. A. B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.9129 · Cited by 291 · see citing works
Meacham, L. R., Chow, E. J., Ness, K. K., Kamdar, K. Y., Chen, Y., Yasui, Y., Oeffinger, K. C., Sklar, C. A., Robison, L. L., & Mertens, A. C. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0555 · Cited by 287 · see citing works
Facemire, C. S., Nixon, A. B., Griffiths, R., Hurwitz, H. I., & Coffman, T. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129973 · Cited by 280 · see citing works
Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease
Heidenreich, P. A., Schnittger, I., Strausś, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., Tate, D. J., Horning, S. J., Hoppe, R. T., & Hancock, S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0805 · Cited by 260 · see citing works
Heart failure associated with sunitinib malate
Khakoo, A. Y., Kassiotis, C., Tannir, N. M., Plana, J. C., Halushka, M. K., Bickford, C. L., Trent, J., Champion, J. C., Durand, J., & Lenihan, D. J. (2008) · Cancer · doi:10.1002/cncr.23460 · Cited by 251 · see citing works
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
Telli, M. L., Witteles, R. M., Fisher, G. A., & Srinivas, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn168 · Cited by 237 · see citing works
Cardiotoxicity Profile of Trastuzumab
Ewer, S. M., & Ewer, M. S. (2008) · Drug Safety · doi:10.2165/00002018-200831060-00002 · Cited by 207 · see citing works
Lorenzo, G. D., Riccardo Autorino, B., Bruni, G., Cartenì, G., Ricevuto, E., Tudini, M., Ficorella, C., Romano, C., Aieta, M., Giordano, A., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp025 · Cited by 207 · see citing works
Nuver, J., Smit, A. J., Wolffenbuttel, B. H. R., Sluiter, W. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.176 · Cited by 194 · see citing works
Understanding Radiation-Induced Vascular Disease
Weintraub, N. L., Jones, W. K., & Manka, D. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.053 · Cited by 193 · see citing works
Jones, L., Liu, Q., Armstrong, G., Ness, K., Yasui, Y., Devine, K., Tonorezos, E., Soares-Miranda, L., Sklar, C., Douglas, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.7511 · Cited by 185 · see citing works
Roychoudhuri, R., Robinson, D., Putcha, V., Cuzick, J. M., Darby, S. C., & Møller, H. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-9 · Cited by 178 · see citing works
Cardiotoxicity in Childhood Cancer Survivors: Strategies for Prevention and Management
Harake, D. E., Franco, V. I., Henkel, J. M., Miller, T. L., & Lipshultz, S. E. (2012) · Future Cardiology · doi:10.2217/fca.12.44 · Cited by 166 · see citing works
Nuver, J., Smit, A. J., Wolffenbuttel, B. H. R., Sluiter, W. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)01043-8 · Cited by 163 · see citing works
Cardiotoxicity of Antitumor Drugs
Menna, P., Salvatorelli, E., & Minotti, G. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800002r · Cited by 163 · see citing works
Blood Pressure and Body Mass Index in Long-Term Survivors of Testicular Cancer
Haugnes, H. S., Aass, N., Fosså, S. D., Dahl, O., Klepp, O., Wist, E., Wilsgaard, T., & Bremnes, R. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.882 · Cited by 154 · see citing works
Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial
DeCensi, A., Maisonneuve, P., Rotmensz, N., et al. (2005) · Circulation · doi:10.1161/01.cir.0000154545.84124.ac · Cited by 151 · see citing works
Ischemic Heart Disease after Breast Cancer Radiotherapy
Darby, S. C., Ewertz, M., & Hall, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1304601 · Cited by 143 · see citing works
Health profiles in 5836 long‐term cancer survivors
Schultz, P. N., Beck, M. L., Stava, C. J., & Vassilopoulou‐Sellin, R. (2003) · International Journal of Cancer · doi:10.1002/ijc.10981 · Cited by 141 · see citing works
Long-Term Complications of Chemotherapy for Germ Cell Tumours
Chaudhary, U. B., & Haldas, J. (2003) · Drugs · doi:10.2165/00003495-200363150-00004 · Cited by 137 · see citing works
Steingart, R. M., Bakris, G. L., Chen, H. X., Chen, M., Force, T. L., Ivy, S. P., Leier, C. V., Liu, G., Lenihan, D. J., Lindenfeld, J. M., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2011.10.018 · Cited by 114 · see citing works
Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer
Boero, I. J., Paravati, A. J., Triplett, D. P., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.12.018 · Cited by 112 · see citing works
Marques‐Aleixo, I., Alves, E. S., Mariani, D., Rizo‐Roca, D., Padrão, A. I., Rocha‐Rodrigues, S., Viscor, G., Torrella, J. R., Ferreira, R. M., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.10.008 · Cited by 108 · see citing works
Long-term platinum retention after treatment with cisplatin and oxaliplatin
Brouwers, E. E. M., Huitema, A. D. R., Beijnen, J. H., & Schellens, J. H. M. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-7 · Cited by 107 · see citing works
Rossari, J. R. F., Metzger, O., Paesmans, M., Saini, K. S., Gennari, A., de Azambuja, E., & Piccart, M. J. (2012) · Journal of Oncology · doi:10.1155/2012/417673 · Cited by 102 · see citing works
Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients
Cardinale, D. M., Bacchiani, G., Beggiato, M., Colombo, A., & Cipolla, C. M. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.01.008 · Cited by 97 · see citing works
Groarke, J. D., Tanguturi, V. K., Hainer, J. M., Klein, J., Moslehi, J. J., Ng, A. K., Forman, D. E., Carli, M. F. D., & Nohria, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.035 · Cited by 94 · see citing works
Qi, W., Shen, Z., Tang, L., & Yao, Y. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12387 · Cited by 88 · see citing works
Schindler, M., Spycher, B. D., Ammann, R. A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30080 · Cited by 87 · see citing works
Hypertension secondary to anti-angiogenic therapy: experience with bevacizumab.
Pande, A. U., Lombardo, J. C., Spangenthal, E. J., et al. (2007) · PubMed · Cited by 85 · see citing works
Radiation-Induced Heart Disease
Filopei, J., & Frishman, W. H. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e3182431c23 · Cited by 84 · see citing works
Stoodley, P. W., Richards, D. A., Boyd, A. C., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.046 · Cited by 72 · see citing works
The Emerging Issue of Cardiac Dysfunction Induced by Antineoplastic Angiogenesis Inhibitors
Tocchetti, C. G., Gallucci, G., Coppola, C., Piscopo, G., Cipresso, C., Maurea, C., Giudice, A., Iaffaioli, R. V., Arra, C., & Maurea, N. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft008 · Cited by 72 · see citing works
Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer
Verma, V., Shah, C., & Mehta, M. P. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.02.006 · Cited by 67 · see citing works
Aydıner, A. (2013) · The Breast · doi:10.1016/j.breast.2013.01.014 · Cited by 66 · see citing works
Treatment of bevacizumab-induced hypertension by amlodipine
Mir, O., Coriat, R., Ropert, S., Cabanes, L., Blanchet, B., Camps, S., Billemont, B., Knebelmann, B., & Goldwasser, F. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9549-5 · Cited by 64 · see citing works
Haas, N. B., Manola, J. B., Ky, B., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0215 · Cited by 61 · see citing works
Riccio, G., Coppola, C., Piscopo, G., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1125056 · Cited by 57 · see citing works
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity
Jones, R. L. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.10.1311 · Cited by 56 · see citing works
Omalizumab for Chronic Urticaria
Maurer, M., Rosén, K. E., & Hsieh, H.-J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1305687 · Cited by 53 · see citing works
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
Nord, C., Fosså, S. D., & Egeland, T. A. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600714 · Cited by 45 · see citing works
Felicetti, F., D’Ascenzo, F., Moretti, C., Corrias, A., Omedè, P., Marra, W. G., Arvat, E., Fagioli, F., Brignardello, E., & Gaïta, F. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314529348 · Cited by 43 · see citing works
Nguyen, P. L., Chen, M. H., Goldhaber, S. Z., et al. (2010) · Cancer · doi:10.1002/cncr.25597 · Cited by 28 · see citing works
Radiation-associated valvular heart disease.
Ds, O., Ra, A., Clark, A. N., et al. (2013) · PubMed · Cited by 27 · see citing works
Post-radiation valvular and coronary artery disease.
Gonzaga, A. T., & Antunes, M. J. (1997) · PubMed · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lassale, C., Curtis, A., Abete, I., van der Schouw, Y. T., Verschuren, W. M. M., Lu, Y., & Bueno-de-Mesquita, H. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-21661-x · Cited by 118 · see citing works
Insights into US life expectancy stagnation from birth cohort mortality dynamics
Abrams, L., Bramajo, O., van Raalte, A., Myrskylä, M., & Mehta, N. K. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519356123 · Cited by 6 · see citing works
- Authors
- Okwuosa, T. M., Anzevino, S., & Rao, R.
- Affiliations
- Rush University Medical Center (US)
- Corresponding author
- Rao, Ruta
- ORCID
- Rao, Ruta
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-08
- Volume
- 93
- Issue
- 1096
- Pages
- 82-90
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2528936641
- Cited by
- 97
- References
- 88
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 18 · 2023: 11 · 2022: 16 · 2021: 14 · 2020: 10 · 2019: 5 · 2018: 3 · 2017: 4
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Postgraduate Medical Journal (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Keywords
- cancer survivors, cardiovascular disease, anthracycline cardiotoxicity, radiation-induced cardiotoxicity, hormone therapy, breast cancer, prostate cancer, cardiovascular risk screening, statin therapy, ACE inhibitors, beta-blockers, aspirin, lifestyle modification, cardio-oncology
- MeSH terms
- Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Cardiovascular Diseases, Humans, Neoplasms, Radiotherapy, Risk Factors, United States, Practice Guidelines as Topic, Survivors, Risk Reduction Behavior, Early Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
